Global Nuclear Medicine & Radiopharmaceuticals Market Research Report 2023

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

The global Nuclear Medicine & Radiopharmaceuticals market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine & Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine & Radiopharmaceuticals.

The Nuclear Medicine & Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nuclear Medicine & Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nuclear Medicine & Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Nuclear Medicine & Radiopharmaceuticals

1.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type

1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Value Comparison by Type (2023-2029)

1.2.2 Diagnostic

1.2.3 Therapeutic

1.3 Nuclear Medicine & Radiopharmaceuticals Segment by Application

1.3.1 Global Nuclear Medicine & Radiopharmaceuticals Market Value by Application: (2023-2029)

1.3.2 Oncology

1.3.3 Thyroid

1.3.4 Cardiology

1.3.5 Others

1.4 Global Nuclear Medicine & Radiopharmaceuticals Market Size Estimates and Forecasts

1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue 2018-2029

1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Sales 2018-2029

1.4.3 Global Nuclear Medicine & Radiopharmaceuticals Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturers (2018-2023)

2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Manufacturers (2018-2023)

2.4 Global Nuclear Medicine & Radiopharmaceuticals Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Product Type & Application

2.7 Nuclear Medicine & Radiopharmaceuticals Market Competitive Situation and Trends

2.7.1 Nuclear Medicine & Radiopharmaceuticals Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Nuclear Medicine & Radiopharmaceuticals Players Market Share by Revenue

2.7.3 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Nuclear Medicine & Radiopharmaceuticals Global Nuclear Medicine & Radiopharmaceuticals Sales by Region: 2018-2029

3.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region: 2018-2023

3.2.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region: 2024-2029

3.3 Global Nuclear Medicine & Radiopharmaceuticals Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2018-2029

3.3.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2018-2023

3.3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2024-2029

3.4 North America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country

3.4.1 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2029)

3.4.3 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country

3.5.1 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2029)

3.5.3 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country

3.6.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2029)

3.6.3 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country

3.7.1 Latin America Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2029)

3.7.3 Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country

3.8.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2029)

3.8.3 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2018-2029)

4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2018-2023)

4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2024-2029)

4.1.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2018-2029)

4.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2018-2029)

4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2018-2023)

4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2024-2029)

4.2.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2018-2029)

4.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2018-2029)

5.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2018-2029)

5.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2018-2023)

5.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2024-2029)

5.1.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2018-2029)

5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2018-2029)

5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2018-2023)

5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2024-2029)

5.2.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2018-2029)

5.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2018-2029)

6.1 China Isotope & Radiation

6.1.1 China Isotope & Radiation Corporation Information

6.1.2 China Isotope & Radiation Description and Business Overview

6.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolio

6.1.5 China Isotope & Radiation Recent Developments/Updates

6.2 Dongcheng

6.2.1 Dongcheng Corporation Information

6.2.2 Dongcheng Description and Business Overview

6.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolio

6.2.5 Dongcheng Recent Developments/Updates

6.3 Jaco

6.3.1 Jaco Corporation Information

6.3.2 Jaco Description and Business Overview

6.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Product Portfolio

6.3.5 Jaco Recent Developments/Updates

6.4 Ciaeriar

6.4.1 Ciaeriar Corporation Information

6.4.2 Ciaeriar Description and Business Overview

6.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Portfolio

6.4.5 Ciaeriar Recent Developments/Updates

6.5 Advanced Molecular-imaging Solution

6.5.1 Advanced Molecular-imaging Solution Corporation Information

6.5.2 Advanced Molecular-imaging Solution Description and Business Overview

6.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Portfolio

6.5.5 Advanced Molecular-imaging Solution Recent Developments/Updates

6.6 Shanghai Atom Kexing

6.6.1 Shanghai Atom Kexing Corporation Information

6.6.2 Shanghai Atom Kexing Description and Business Overview

6.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Portfolio

6.6.5 Shanghai Atom Kexing Recent Developments/Updates

7.1 Nuclear Medicine & Radiopharmaceuticals Industry Chain Analysis

7.2 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Nuclear Medicine & Radiopharmaceuticals Production Mode & Process

7.4 Nuclear Medicine & Radiopharmaceuticals Sales and Marketing

7.4.1 Nuclear Medicine & Radiopharmaceuticals Sales Channels

7.4.2 Nuclear Medicine & Radiopharmaceuticals Distributors

7.5 Nuclear Medicine & Radiopharmaceuticals Customers

8.1 Nuclear Medicine & Radiopharmaceuticals Industry Trends

8.2 Nuclear Medicine & Radiopharmaceuticals Market Drivers

8.3 Nuclear Medicine & Radiopharmaceuticals Market Challenges

8.4 Nuclear Medicine & Radiopharmaceuticals Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Nuclear Medicine & Radiopharmaceuticals Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Nuclear Medicine & Radiopharmaceuticals Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Nuclear Medicine & Radiopharmaceuticals Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Nuclear Medicine & Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Nuclear Medicine & Radiopharmaceuticals, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Product Type & Application

    Table 12. Global Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Nuclear Medicine & Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine & Radiopharmaceuticals as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2018-2023) & (K Units)

    Table 18. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2018-2023)

    Table 19. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2024-2029) & (K Units)

    Table 20. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2024-2029)

    Table 21. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2018-2023)

    Table 23. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2024-2029)

    Table 25. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)

    Table 27. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)

    Table 28. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type (2018-2023)

    Table 51. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type (2024-2029)

    Table 52. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2018-2023)

    Table 53. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2024-2029)

    Table 54. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2018-2023)

    Table 57. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2024-2029)

    Table 58. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2018-2023)

    Table 61. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2024-2029)

    Table 62. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2018-2023)

    Table 63. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2024-2029)

    Table 64. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2018-2023)

    Table 67. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2024-2029)

    Table 68. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Application (2024-2029)

    Table 70. China Isotope & Radiation Corporation Information

    Table 71. China Isotope & Radiation Description and Business Overview

    Table 72. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product

    Table 74. China Isotope & Radiation Recent Developments/Updates

    Table 75. Dongcheng Corporation Information

    Table 76. Dongcheng Description and Business Overview

    Table 77. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product

    Table 79. Dongcheng Recent Developments/Updates

    Table 80. Jaco Corporation Information

    Table 81. Jaco Description and Business Overview

    Table 82. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Jaco Nuclear Medicine & Radiopharmaceuticals Product

    Table 84. Jaco Recent Developments/Updates

    Table 85. Ciaeriar Corporation Information

    Table 86. Ciaeriar Description and Business Overview

    Table 87. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product

    Table 89. Ciaeriar Recent Developments/Updates

    Table 90. Advanced Molecular-imaging Solution Corporation Information

    Table 91. Advanced Molecular-imaging Solution Description and Business Overview

    Table 92. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product

    Table 94. Advanced Molecular-imaging Solution Recent Developments/Updates

    Table 95. Shanghai Atom Kexing Corporation Information

    Table 96. Shanghai Atom Kexing Description and Business Overview

    Table 97. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product

    Table 99. Shanghai Atom Kexing Recent Developments/Updates

    Table 100. Key Raw Materials Lists

    Table 101. Raw Materials Key Suppliers Lists

    Table 102. Nuclear Medicine & Radiopharmaceuticals Distributors List

    Table 103. Nuclear Medicine & Radiopharmaceuticals Customers List

    Table 104. Nuclear Medicine & Radiopharmaceuticals Market Trends

    Table 105. Nuclear Medicine & Radiopharmaceuticals Market Drivers

    Table 106. Nuclear Medicine & Radiopharmaceuticals Market Challenges

    Table 107. Nuclear Medicine & Radiopharmaceuticals Market Restraints

    Table 108. Research Programs/Design for This Report

    Table 109. Key Data Information from Secondary Sources

    Table 110. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Nuclear Medicine & Radiopharmaceuticals

    Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Nuclear Medicine & Radiopharmaceuticals Market Share by Type in 2022 & 2029

    Figure 4. Diagnostic Product Picture

    Figure 5. Therapeutic Product Picture

    Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Nuclear Medicine & Radiopharmaceuticals Market Share by Application in 2022 & 2029

    Figure 8. Oncology

    Figure 9. Thyroid

    Figure 10. Cardiology

    Figure 11. Others

    Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)

    Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Sales (2018-2029) & (K Units)

    Figure 15. Global Nuclear Medicine & Radiopharmaceuticals Average Price (USD/Unit) & (2018-2029)

    Figure 16. Nuclear Medicine & Radiopharmaceuticals Report Years Considered

    Figure 17. Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturers in 2022

    Figure 18. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers in 2022

    Figure 19. The Global 5 and 10 Largest Nuclear Medicine & Radiopharmaceuticals Players: Market Share by Revenue in 2022

    Figure 20. Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 21. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 22. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2018-2029)

    Figure 23. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2018-2029)

    Figure 24. U.S. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Canada Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2018-2029)

    Figure 27. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2018-2029)

    Figure 28. Germany Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. France Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. U.K. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Italy Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Russia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2018-2029)

    Figure 34. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2018-2029)

    Figure 35. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. India Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Australia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. China Taiwan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Indonesia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Thailand Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Malaysia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2018-2029)

    Figure 45. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2018-2029)

    Figure 46. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Argentina Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2018-2029)

    Figure 50. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2018-2029)

    Figure 51. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. UAE Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Global Sales Market Share of Nuclear Medicine & Radiopharmaceuticals by Type (2018-2029)

    Figure 55. Global Revenue Market Share of Nuclear Medicine & Radiopharmaceuticals by Type (2018-2029)

    Figure 56. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Type (2018-2029)

    Figure 57. Global Sales Market Share of Nuclear Medicine & Radiopharmaceuticals by Application (2018-2029)

    Figure 58. Global Revenue Market Share of Nuclear Medicine & Radiopharmaceuticals by Application (2018-2029)

    Figure 59. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Application (2018-2029)

    Figure 60. Nuclear Medicine & Radiopharmaceuticals Value Chain

    Figure 61. Nuclear Medicine & Radiopharmaceuticals Production Process

    Figure 62. Channels of Distribution (Direct Vs Distribution)

    Figure 63. Distributors Profiles

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed